ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "joint destruction"

  • Abstract Number: 1981 • 2019 ACR/ARP Annual Meeting

    Functional Differences Between Osteoclasts and Osteoclast-like Cells Differentiated from Peripheral Blood Mononuclear Cells in Patients with Rheumatoid Arthritis

    Kazuhiro Yokota1, Yoshimi Aizaki 1, Shinya Tanaka 2, Kojiro Sato 3, Yasuto Araki 1, Noritsune Kouzu 4, Yuho Kadono 2, Hiromi Oda 5 and Toshihide Mimura 1, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 2Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan, 3Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Tochigi, Japan, 4Medical Kouzu orthopedic and Yachiyo radiation center, Chiba, Japan, 5Department of Orthopedic Surgery, Faculty of Medicine, Saitama Medical University, Saitama, Japan

    Background/Purpose: Osteoclasts (OCs) are giant multinucleated cells formed from precursors of the monocyte/macrophage lineage and are believe to play a major role in the bone…
  • Abstract Number: 1498 • 2018 ACR/ARHP Annual Meeting

    Serum MMP-3 More Than 155ng/Ml at Baseline Predicts One-Year Radiographic Progression in Patients with Rheumatoid Arthritis

    Jian-Da Ma1, Jun-Wei Wang2, Yan-Hui Xu2, Kui-Min Yang2, Le-Feng Chen2, Jian-Zi Lin2 and Lie Dai2, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangdong, China, 2Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

    Background/Purpose: Core disease activity indicators of rheumatoid arthritis (RA) have been found to be limited in predicting joint destruction progression. We previously reported that continuously…
  • Abstract Number: 53 • 2017 ACR/ARHP Annual Meeting

    Poly-γ-Glutamic Acid Inhibits RANKL- Induced Osteoclast Differentiation and Prevents Bone Destruction in Rheumatoid Arthritis: Human and CIA Mouse Model

    Bitnara Lee1, Jong-Dae Ji2 and Tae-Hwan Kim1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Rheumatology, Korea University Hospital, Seoul, Korea, Republic of (South)

    Background/Purpose: Rheumatoid arthritis (RA) is an inflammatory disease that is characterized by chronic inflammation and bone destruction. Osteoclasts, which are bone-resorbing cells, are generally known…
  • Abstract Number: 250 • 2017 ACR/ARHP Annual Meeting

    An Ultrasonographic Study for Investigating Relationships with the Signs of Uric Deposition and Bone Erosion in Patients with Hyperuricemia

    Ikuko Tanaka1, Takashi Kato2, Motokazu Kai3, Kunikazu Ogawa3, Hisaji Oshima4 and Shigenori Tamaki5, 1NAGOYA Rheumatology Clinic, Nagoya, Japan, 2Department of Radiology, National Center for Geratrics and Gerontology, Obu, Japan, 3Mie Rheumatology Clinic, Suzuka, Japan, 4Department of Connective Tissue Diseases, National Tokyo Medical Center, Tokyo, Japan, 5Nagoya Rheumatology Clinic, Nagoya, Japan

    Background/Purpose: Joint ultrasonography (US) is a noninvasive examination that can evaluate arthritis and uric acid deposition at gout attacks. The purpose of this study was…
  • Abstract Number: 453 • 2017 ACR/ARHP Annual Meeting

    The Therapy with Tocilizumab Is Not Associated with Periarticular Demineralisation and Finger Joint Space Narrowing in Rheumatoid Arthritis

    Alexander Pfeil1, Ottar Gadeholt2, Joachim Böttcher3, Diane Renz4, Peter Oelzner1 and Gunter Wolf1, 1Department of Internal Medicine III, Jena University Hospital, Jena, Germany, 2Rheumatology/Immunology, Medical Clinic II, University Clinic Wuerzburg, Wuerzburg, Germany, 3Institut of Interventional and Diagnostic Radiology, SRH Waldklinikum Gera, Gera, Germany, 4Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany

    Background/Purpose: Digital X-ray Radiogrammetry (DXR) and Computer-Aided Joint Space Analysis (CAJSA) are established computer based techniques for the quantification of metacarpal bone mineral density and…
  • Abstract Number: 2792 • 2017 ACR/ARHP Annual Meeting

    Th22 Cells Are a Potent Inducer of Osteoclastogenesis in Rheumatoid Arthritis

    Yusuke Miyazaki1, Shingo Nakayamada2, Satoshi Kubo1, Kazuhisa Nakano2, Kei Sakata3, Shigeru Iwata4, Ippei Miyagawa5 and Yoshiya Tanaka6, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyshu, Japan, 4First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 6The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose: CD4+ T cells can differentiate into functionally distinct subsets and play a pivotal role in rheumatoid arthritis (RA). Th22 cells have been identified as…
  • Abstract Number: 2909 • 2017 ACR/ARHP Annual Meeting

    Only Very High Radiographic Progression Affects HAQ-DI, Results from the Swiss Scqm Cohort

    Ruediger Mueller1, Reto Thalmann2, Hendrik Schulze-Koops3, Nicole Graf4 and Johannes von Kempis2, 1Rheumatology, MD, St. Gallen, Switzerland, 2Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, 3Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany, 4Graf Biostatistics, Winterthur, Switzerland

    Background/Purpose: The aim of treatment of rheumatoid arthritis is to control disease activity and to inhibit joint damage. Progression of damage is analysed by conventional…
  • Abstract Number: 2263 • 2016 ACR/ARHP Annual Meeting

    Apolipoprotein E Regulates Inflammation and Joint Destruction during Antigen-Induced Arthritis (AIA)

    Giuliana Ascone1, Irene Di Ceglie1, Wouter de Munter1, Birgitte Walgreen2, Annet Sloetjes1, Peter M. van der Kraan1, Ernst Lindhout3, Mike Martens3 and Peter L. E. M. van Lent1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Experimental, Radboud university medical center, Nijmegen, Netherlands, 3Future Diagnostics Solutions (FDs), Wijchen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease largely driven by immune complexes and their interaction with FcγRs present on macrophages within the synovium.…
  • Abstract Number: 2369 • 2016 ACR/ARHP Annual Meeting

    Obesity and Severity of Joint Space Narrowing Are Associated with Viscosupplementation Failure in Patients with Knee Osteoarthritis. Post-Hoc Analysis of a Double-Blind, Controlled, Multicentre, Randomized Trial

    Florent Eymard1, Xavier Chevalier2 and Thierry Conrozier3, 1Department of Rheumatology, APHP Henri Mondor Hospital, Paris, France, 2Rheumatology, Hopital Henri Mondor, Créteil, France, 3Department of Rheumatology,, Nord Franche-Comté Hospital, Belfort, France

    Background/Purpose:   Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. We aimed to identify clinical…
  • Abstract Number: 588 • 2016 ACR/ARHP Annual Meeting

    Radiographic Progression Is Less Significant in Anti-Carbamylated Antibody-Positive Patients with Rheumatoid Arthritis (RA) Who Were Clinically Active and Under the Treatment with Biological Dmards

    Kazuko Shiozawa1, Ken Tsumiyama2 and Shunichi Shiozawa2, 1The Rheumatic Diseases Center, Kohnan Kakogawa Hospital, Kakogawa, Japan, 2Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan

    Background/Purpose: A newly discovered anti-carbamylated protein antibody (anti-CarP) is found prior to disease-onset, associates with the conversion towards arthralgia and with a more severe disease…
  • Abstract Number: 509 • 2015 ACR/ARHP Annual Meeting

    In Early Undifferentiated Polyarthritis, 14-3-3η Seroreversion or Sustained Negativity Is Associated with Better Radiographic Outcomes, Even in DAS-28 Remitters

    Gilles Boire1,2, Nathalie Carrier3, Artur de Brum-Fernandes1,4, Patrick Liang1,4, Ariel Masetto2,5, Yuan Gui6, Jane Savill6, Sara Michienzi6, Henri Ménard7, Walter Maksymowych8 and Anthony Marotta6, 1Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 2Department of Medicine/Division of Rheumatology, University of Sherbrooke, Sherbrooke, QC, Canada, 3Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 5Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 6Augurex Life Sciences Corp., Vancouver, BC, Canada, 7MSK Research Axis, McGill University Health Center Research Institute, Montreal, QC, Canada, 8Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Advancements in RA treatment approaches with DMARDs and biological agents have enabled disease remission goals that were previously considered unattainable. The concept of "tight…
  • Abstract Number: 1318 • 2015 ACR/ARHP Annual Meeting

    Prediction of Large Joint Destruction in Patients with Rheumatoid Arthritis Using FDG-PET/CT: A Prospective Study

    Takahito Suto, Koichi Okamura, Yukio Yonemoto, Chisa Okura and Kenji Takagishi, Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

    Background/Purpose: The assessments of joint damage in patients with rheumatoid arthritis (RA) are mainly restricted to small joints in the hands and feet. However, the…
  • Abstract Number: 1607 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner

    Chikashi Terao1, Noriyuki Yamakawa2, Koichiro Yano3, I.M. Markusse4, Katsunori Ikari3, Shinji Yoshida3, Moritoshi Furu5, Motomu Hashimoto5, Hiromu Ito5, Takao Fujii6, Koichiro Ohmura7, Kosaku Murakami7, Meiko Takahashi2, Masahide Hamaguchi8, Yasuharu Tabara2, Atsuo Taniguchi3, Shigeki Momohara3, Soumya Raychaudhuri9, Cornelia F. Allaart10, Hisashi Yamanaka11, Tsuneyo Mimori12 and Fumihiko Matsuda13, 1Departments of Genetics and Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4LUMC, Leiden, Netherlands, 5Department of the Control for Rheumatic Diseases, Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6Dept of Rheum/Clinical Immun, Kyoto University Graduate School of Medicine, Kyoto, Japan, 7Dept of Rheum & Clinical Immun, Kyoto Univ Grad School of Med, Kyoto, Japan, 8Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 9Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 10Rheumatology, LUMC, Leiden, Netherlands, 11Tokyo Women's Medical University, Tokyo, Japan, 12Dept of Rheum & Clinical Immun, Kyoto Univ Grad Schl of Med, Kyoto, Japan, 13Genomic Center, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease leading to joint destruction. Although many studies have addressed correlates associated with the speed of joint destruction,…
  • Abstract Number: 3189 • 2015 ACR/ARHP Annual Meeting

    Enhancement of Mitochondrial Biogenesis Inhibits Cell Proliferation and MMP-3/RANKL Secretion in Rheumatoid Arthritis Fibroblast-like Synovial Cells and Joint Destruction in Arthritis Model Mice

    Takeshi Ueha1, Yoshitada Sakai1, Masayuki Morishita2, Toshihisa Maeda2, Koji Fukuda2, Miho Inoue2, Risa Harada2, Masaya Minoda2, Yasushi Miura3,4,5, Akira Hashiramoto6 and Masahiro Kurosaka1,4, 1Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 2Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan, 3Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan, 4Orthpaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan, 5Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, 6Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose: Joint destruction in rheumatoid arthritis (RA) progresses via the hyperproliferation of the synovium and secretion of MMP-3/RANKL from fibroblast-like synoviocytes (FLS). In tumors, we previously…
  • Abstract Number: 2505 • 2014 ACR/ARHP Annual Meeting

    Long-Term Treatment with Tocilizumab (TCZ) Strongly Suppresses Joint Destruction in Biologic-naïve Patients with Rheumatoid Arthritis (RA) Regardless of Inflammation Status

    Akira Sagawa, Sagawa Akira Rheumatology Clinic, Sapporo,060-0001, Japan

    Background/Purpose: It is still difficult to completely prevent the progression of joint destruction with any of the currently available biologics. It has been reported that…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology